Literature DB >> 14623367

Chromosome aberrations in a schizophrenia population.

Osman Demirhan1, Deniz Taştemir.   

Abstract

Cytogenetic abnormalities with schizophrenia may provide a valuable clue to the identification of target loci and successful search for major genes. We have performed chromosomal examinations by using the GTG banding technique on 134 schizophrenics. In 43 patients (32%), random numerical and structural aberrations were detected. Structural aberrations predominated and usually consisted of deletions and inversion of various chromosomes. Numerical changes were present in one or two cells in 14 cases including trizomy 21, marker and acentric chromosomes, and 47,XXY. The seven cases with pericentric inversion and enlargement of the heterochromatin region of chromosome 9 (inv(9); 9qh+) were observed in the study. The incidence (5.2%) of inv(9) and 9qh+ in our schizophrenic patients were found higher than the general population, suggesting that a susceptibility locus for schizophrenia may be located at pericentromeric region of chromosome 9. Our study have detected 1q21, 7q23, inv(9), 9qh+, 11q23, 21q22, 22q11-13 and Xp11-q13 suggested that these chromosomal lesions are prevalent in schizophrenics. The reason for this might be that these anomalies increase risk for schizophrenia in a relatively nonspecific way, such as contributing to disruption of normal embryogenesis of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623367     DOI: 10.1016/s0920-9964(02)00504-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

1.  Association of thrombospondin 1 gene with schizophrenia in Korean population.

Authors:  Hae Jeong Park; Su Kang Kim; Jong Woo Kim; Won Sub Kang; Joo-Ho Chung
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

2.  Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.

Authors:  Gen-Min Lin; Yu-Jung Chen; De-Jhen Kuo; Lamin E S Jaiteh; Yi-Chung Wu; Tzu-Shun Lo; Yi-Hwei Li
Journal:  Schizophr Bull       Date:  2011-11-01       Impact factor: 9.306

3.  Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients.

Authors:  Y J La; C L Wan; H Zhu; Y F Yang; Y S Chen; Y X Pan; G Y Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-12-14       Impact factor: 3.575

Review 4.  Clinical perspectives on the genetics of schizophrenia: a bottom-up orientation.

Authors:  Willem M A Verhoeven; Siegfried Tuinier
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  Association study between the pericentrin (PCNT) gene and schizophrenia.

Authors:  Shusuke Numata; Masahito Nakataki; Jun-ichi Iga; Toshihito Tanahashi; Yoshihiro Nakadoi; Kazutaka Ohi; Ryota Hashimoto; Masatoshi Takeda; Mitsuo Itakura; Shu-ichi Ueno; Tetsuro Ohmori
Journal:  Neuromolecular Med       Date:  2009-11-24       Impact factor: 3.843

6.  Why sex differences in schizophrenia?

Authors:  Rena Li; Xin Ma; Gang Wang; Jian Yang; Chuanyue Wang
Journal:  J Transl Neurosci (Beijing)       Date:  2016-09

7.  Acquired pericentric inversion of chromosome 9 in acute myeloid leukemia.

Authors:  A M Udayakumar; A V Pathare; D Dennison; J A Raeburn
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

8.  De novo pericentric inversion of chromosome 9 in congenital anomaly.

Authors:  Seon-Yong Jeong; Bo-Young Kim; Jae Eun Yu
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

9.  Klinefelter's syndrome (mosaic) with chromosome 9 inv and schizophrenia.

Authors:  R Ponnudurai; B Srinivasan; R Sumitha; Teena Koshy; Solomon S D Paul; Anjana Rani
Journal:  Indian J Psychiatry       Date:  2012-01       Impact factor: 1.759

Review 10.  Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia.

Authors:  Nitin Gogtay
Journal:  Schizophr Bull       Date:  2007-09-29       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.